Since tumor growth is a result of the constant crosstalk between a tumor and its surrounding microenvironment, leading to neoangiogenesis and immune escape, further studies on the role of RPS6 in this crosstalk contribute to developing additional strategies combining anti-angiogenic therapy and immunotherapy against cancer [349,350]. The gene discussed is RPS6; the disease is cancer.